T he Epidemiology of Aging A nne B. N ewman • J ane A. C auley E ditors T he Epidemiology of Aging E ditors A nne B. N ewman J ane A. C auley Chair, Department of Epidemiology Department of Epidemiology Director, Center for Aging G raduate School of Public Health and Population Health U niversity of Pittsburgh Professor of Epidemiology, Medicine P ittsburgh, PA, U SA and Clinical & Translational Science Graduate School of Public Health University of Pittsburgh Pittsburgh, PA, USA I SBN 978-94-007-5060-9 I SBN 978-94-007-5061-6 (eBook) D OI 10.1007/978-94-007-5061-6 S pringer Dordrecht Heidelberg New York London L ibrary of Congress Control Number: 2012954272 © Springer Science+Business Media Dordrecht 2 012 T his work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi c ally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi l ms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi c ally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. T he use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. W hile the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. P rinted on acid-free paper S pringer is part of Springer Science+Business Media (www.springer.com) F or Frank, Who understands me and takes care of me, With all my love. A BN F or Kathryn and Nora, W ho bring me great joy; Their unconditional love keeps me whole. J AC F oreword I n recent decades, the fi e ld of the epidemiology of aging has grown substan- tially in breadth and depth. The many cumulative successes in public health over the past century have led to a larger proportion of the population survi- ving to achieve longevity, but this has come with an increase in the number of individuals who eventually experience disability. The fi e ld of the epidemiology of aging evaluates these public health successes and addresses the new challenges that have come with them. The focus is not only on the length of life, but on the quality of life. A s a core discipline of public health, epidemiology serves to identify key problems and the rates at which they occur, determine risk factors for these problems in populations, and then formulate interventions to reduce the rates and risk factors. Ultimately, the purpose of epidemiology is to inform and improve the health of populations. The epidemiology of aging ranges from the study of the process of aging itself to the study of health outcomes in older adults. In spite of the achievement of longevity, the epidemic of aging includes an overall increase in disability and the need for care and prevention, including primary, secondary and tertiary prevention. As the scope of the problems of aging has become better defi n ed, projections for the future now depend on whether the prevention of age-related chronic disease will compress or expand the period of morbidity at the end of life. Thus, the fi e ld of the epidemiology of aging has been uniquely focused on improving the quality of life in old age. T he defi n ition of old age itself has evolved over time. The age of 65 has been most commonly used as the threshold for old age. Historically, this threshold comes from the age for pension eligibility, initially established in Europe and later adopted in the US for the Social Security Program. Early epidemiologic studies and clinical trials on aging included adults ³6 0 years of age (e.g., the Systolic Hypertension in the Elderly Program [SHEP]) or ³ 6 5 years of age (e.g., the Cardiovascular Health Study [CHS], the Study of Osteoporotic Fractures [SOF]). However, until after age 70, the majority of older adults experience few health problems and mortality risk is fairly low. More recent studies such as the Health Aging and Body Composition Study (Health ABC) and the Lifestyles and Independence Interventions in the Elderly (LIFE) now start at age 70. Life expectancy at age 65 is now close to 20 years and the most rapidly growing age group of older adults is the “oldest old”, generally defi n ed as the group over age 80 or 85. Many ongoing studies on aging (e.g., CHS, SOF) continue to follow their participants well into the tenth decade of life. Studies of healthy aging and longevity focus on exceptional vii viii Foreword survival and health, generally enrolling adults ³ 9 0 years of age or ³ 1 00 years of age, as in the studies of centenarians.. The longevity phenomenon is unique in human history and it is leading to a new and urgent need to understand the oldest old. Thus, many epidemiologic studies and prevention trials now focus on individuals who are ³ 7 0 years of age. T he early-life origins of age-related disease and disability are also of increasing interest. Long-term follow-up of younger cohorts and retrospective designs offer the opportunity to study aging from a life course perspective. Early life experiences, including exposures i n utero, are thought to impact the risk of chronic disease and thus impact aging. In effect, all epidemiologic studies, if carried on for many years, can inform the study of aging. The con- version of the Honolulu Heart Study to the Honolulu Asian Aging Study is an example of the rich progress that can be made in understanding the mid-life origins of aging. The continued follow up of women who are enrolled into the Study of Women’s Health Across the Nation (SWAN), a study of premeno- pausal women who were 42–52 years of age at baseline, will provide important information on the transition from “middle” age to “old” age. It is critical that we continue to capitalize on future opportunities to maintain the long-term follow-up of such rich long-term data sets. T he epidemiology of aging draws from important contributions to the fi e ld of gerontology that have been made in multiple disciplines. Demography has defi n ed the growth of the aging population, while social gerontologists have identifi e d important interactions between health and social factors in older adults. Psychologists have identifi e d the importance of mental and cognitive health to the quality of life in old age. Physiologists and basic scientists have identifi e d aspects of aging processes that can be measured in population studies. Geriatric physicians and allied health professionals have defi n ed important clinical syndromes—such as falling and immobility, weight loss and frailty— which are best managed by addressing their multiple contributing factors. Advances in our imaging techniques have facilitated the identifi c ation of subclinical disease. Together, these diverse disciplines have contributed to the methodology that is used for the multidisciplinary assessment of older adults in population studies and the assessment of solutions to extend the active lifespan. A ging has proven to be an area of inquiry that is particularly well suited to epidemiologic methods. Age-related health conditions are by nature multi- factorial, with contributions from many domains including physical, social and emotional factors. The disabling consequences of disease and of aging are relevant to the entire population, but they are highly heterogeneous. Large population studies are needed to understand this variability and complexity. Older adults have high rates of the common chronic diseases and many risk factors for these diseases have been identifi e d in disease-specifi c epidemio- logic cohort studies. Disability has come to be recognized as a highly variable dynamic process and various aspects of disability have been targeted as key endpoints for identifying risk factors and designing prevention trials. Such trials are currently being designed to encompass these critical issues of variability and the need for generalizability. Foreword ix T hough the demographic imperative is clear, there is a need to attract more investigators to the fi e ld of the Epidemiology of Aging. The chapters that follow form a foundation of knowledge that hopefully will serve to propel careers and research in the fi e ld forward. We hope that the quality of aging throughout the world can improve as a result. Department of Epidemiology Anne B. Newman Graduate School of Public Health Jane A. Cauley University of Pittsburgh Pittsburgh, PA, USA